INS and type 1 diabetes mellitus: Notably, a substantial majority (85% to 90%) of individuals with T1DM have autoantibodies that specifically target key proteins, including insulin, glutamic acid decarboxylase 65, insulinoma-associated autoantigen 2, zinc transporter 8, and tyrosine phosphatase IA-2β.